Non-hodgekin lymphoma (NHL-both follicular & diffuse large cell)

Clinical trials for Non-hodgekin lymphoma (NHL-both follicular & diffuse large cell) explained in plain language.

Never miss a new study

Get alerted when new Non-hodgekin lymphoma (NHL-both follicular & diffuse large cell) trials appear

Sign up with your email to follow new studies for Non-hodgekin lymphoma (NHL-both follicular & diffuse large cell), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New CAR-T therapy aims to tackle tough blood cancers

Disease control Not yet recruiting

This trial tests a new treatment called SHB-02-CD19, which uses a patient's own immune cells engineered to attack cancer cells that have a protein called CD19. It is for children and adults with B-cell cancers (like leukemia or lymphoma) that have come back or not responded to at…

Matched conditions: NON-HODGEKIN LYMPHOMA (NHL-BOTH FOLLICULAR & DIFFUSE LARGE CELL)

Phase 1/2 • Sponsor: Sheba Medical Center • Aim: Disease control

Last updated Jun 27, 2026 12:02 UTC

Non-hodgekin lymphoma (NHL-both follicular & diffuse large cell)

Get alerted when new Non-hodgekin lymphoma (NHL-both follicular & diffuse large cell) trials appear

New CAR-T therapy aims to tackle tough blood cancers